HealthDay News — The annual incidence of treatment-related acute myeloid leukemia (tAML) has increased, in addition to an increase in the distribution of primary cancers, defined as the first ...

In this study, researchers aimed to assess guideline-concordant colorectal cancer care to quantify how much variation is ...

Investigators sought to determine whether the NHS Lung Cancer Screening Programme met its goals for nationwide lung cancer screening.

Investigators sought to determine whether a ctDNA-guided adjuvant atezolizumab dosing strategy was more cost-effective than a standard stage-based strategy for patients with MIBC.

In this study, researchers evaluated the characteristics, clinical outcomes, and hematologic biomarkers associated with OS in patients with resectable NSCLC treated with neoadjuvant chemoimmunotherapy ...

Researchers sought to determine how much is known about the effects of GLP-1 use on the efficacy and outcomes of radiotherapy in patients with cancer.

An update on CAR-T therapies for MM and B-cell NHL presented at the 2026 ONA Summit highlighted the integral role of oncology nurses in ensuring patients achieve optimal outcomes.

More than tripled risk of five-year mortality seen with use of complementary and alternative medicine alone compared with traditional therapies.

Researchers used GBD data, MR, and a hospital-based survey to investigate the potential relationship between fruit intake and lung cancer risk.

A multicenter, single-arm, phase 2 trial investigated the activity and safety of varnimcabtagene autoleucel in adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia.

Biomarker testing has the potential to streamline diagnosis, treatment planning, and anticipation of treatment risks, if done right.

Cumulative incidence of ipsilateral invasive breast cancer similar when iiBCs detected at primary surgery in the standard treatment group were considered.